Cite

HARVARD Citation

    Park, S. et al. (n.d.). Outcome of Lower-Risk Patients with Myelodysplastic Syndromes without 5Q Deletion after Failure of Erythropoiesis Stimulating Agents. Leukemia research. pp. S33-. [Online]. 
  
Back to record